HomeFileStructural heart disease

Structural heart disease

View Category

Other

ESC 2024 | TRI.Fr: Transcatheter Tricuspid Repair for the Treatment of Tricuspid Regurgitation

Right-sided heart failure and tricuspid regurgitation (TR) are associated with poor quality of life and an increased...
Dr. Omar Tupayachi -
Learn More
Mitral valve

ESC 2024 | MATERHORN Trial: Transcatheter vs. Surgical Mitral Repair in Patients with Heart Failure and Secondary Mitral Regurgitation

European guidelines consider transcatheter therapy as an alternative for patients with secondary mitral regurgitation who are not...
Dr. Omar Tupayachi -
Learn More
Mitral valve

ESC 2024 | RESHAPE-HF2: MitraClip in Heart Failure and Moderate to Severe Mitral Regurgitation

The aim of this study was to assess the effectiveness of MitraClip in patients with secondary mitral...
Dr. Omar Tupayachi -
Learn More
Other

ESC 2024 | STOP-or-NOT Trial: Optimal Management of Renin-Angiotensin System Inhibition Before Non-Cardiac Surgery

Researchers conducted a multicenter, randomized study to assess the continuation of renin-angiotensin system inhibition (RASI) before major...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

SAFE-Vein: Percutaneous Closure Devices in Complex Venous Accesses

For certain structural interventions and procedures in the field of interventional electrophysiology, complex venous access (CVA) using...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Definite Pacemaker Implantation Predictors in TAVR High Implant Using Cusp Overlap

TAVR has been shown beneficial but one of the current challenges especially in low risk populations is...
solaci -
Learn More
Structural heart disease

Do Leadless Pacemakers After TAVR Offer Benefits?

The need for pacemaker after transcatheter aortic valve replacement (TAVR) remains slightly higher than with surgery, especially...
Dr. Carlos Fava -
Learn More
Structural heart disease

When to Perform Non-Cardiac Surgery After TAVR

Transcatheter aortic valve replacement (TAVR) is becoming increasingly common, not only in high-risk or inoperable patients but...
Dr. Carlos Fava -
Learn More